Patents for A61L 33 - Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment (5,725)
09/2003
09/03/2003EP0842207B1 Fluoroligomer surface modifiers for polymers and articles made therefrom
09/02/2003US6613432 Plasma-deposited coatings, devices and methods
09/02/2003US6613083 Stent device and method
08/2003
08/28/2003WO2003070125A1 Composite stent with polymeric covering and bioactive coating
08/28/2003US20030163198 Methods for surface modification
08/28/2003US20030163187 Non-invasive heating of implanted vascular treatment device
08/28/2003US20030163186 Vascular prosthesis impregnated with crosslinked dextran
08/28/2003US20030162905 Having modified a surface of a medical device
08/28/2003US20030161938 Base layer selected from hyaluronic acid, poly-lysine and a peptide, and biocompatible layer selected from polysaccharides, lipids, proteins, heparin, heparan sulfate, hirudin and aprotinin
08/28/2003CA2470824A1 Composite stent with polymeric covering and bioactive coating
08/27/2003EP1338648A1 Pharmaceutically acceptable fixed-dried human blood platelets
08/27/2003EP1337285A1 Implants with a phosphazene-containing coating
08/27/2003CN1438042A Microcrystal cellulose application
08/21/2003WO2003068289A1 Polymer coating for medical devices
08/21/2003US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa.
08/21/2003US20030157142 Implants with a phosphazene-containing coating
08/21/2003CA2476431A1 Coating having polymerized silane derivatives for medical devices
08/13/2003EP1334737A2 Anti-adhesive coating and uses thereof
08/13/2003EP1333871A1 Hydrophobic multicomponent heparin conjugates, a preparing method and a use thereof
08/13/2003CN1435263A Hematostatic gel
08/12/2003US6605115 Method and composition for inhibiting cardiovascular cell proliferation
08/12/2003US6605114 Bonding with implantable stent with attractant coating; preventing coagulation
08/12/2003CA2207740C Coating process
08/07/2003WO2002058753A9 Coating for implantable devices and a method of forming the same
08/07/2003US20030149173 Crosslinked polymer compositions and methods for their use
08/06/2003EP1332236A2 Treatment for cold worked nitinol
08/06/2003CN1434072A High-strength antimicrobial dialdehyde starch crosslinked chitosan membane and preparation method and use thereof
08/05/2003US6603040 Wherein X1 comprises a first photoreactive species; X2 comprises a second photoreactive species; Y comprises a nonpolymeric core molecule comprising an aromatic group; and Z comprises at least one charged group. The Y core can include
08/05/2003US6602272 Devices configured from heat shaped, strain hardened nickel-titanium
08/05/2003US6602269 Embolic devices capable of in-situ reinforcement
07/2003
07/31/2003WO2003061689A1 Thrombin derived peptides for promoting cardiac tissue repair
07/31/2003WO2003061481A1 Occlusion device with non-thrombogenic properties
07/31/2003CA2511223A1 Thrombin derived peptides for promoting cardiac tissue repair
07/30/2003EP1330484A2 Two dimensional polyamides prepared from unsaturated carboxylic acids and amines
07/29/2003US6599558 Treating metal surfaces to enhance bio-compatibility and/or physical characteristics
07/24/2003WO2003059408A2 Surgical patches with a biological active agent
07/24/2003CA2470499A1 Surgical patches with a biological active agent
07/23/2003EP1328570A2 Crosslinked polyamide
07/23/2003EP1251973A4 Plasma-deposited coatings, devices and methods
07/23/2003EP0948370B1 Process for preparing polyurethane-peo-heparin coating compositions
07/22/2003US6596699 Nucleic acid coating compositions and methods
07/22/2003US6596304 Method for preparing two-layer bicomposite collagen material for preventing post-operative adhesions
07/16/2003EP1159302A4 Non-thrombogenic coating composition and methods for using same
07/16/2003CN1429547A Coronary artery skeleton medicinal coating for preventing restenosis of blood vessel
07/10/2003WO2003055531A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
07/10/2003WO2003032086A3 Carl for bioelectronics: substrate linkage using a conductive layer
07/10/2003WO2002024051A3 Endoscopic targeting method and system
07/10/2003US20030129130 Drug delivery; microparticles immobilized on polymer surface
07/10/2003CA2470684A1 A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
07/08/2003US6590054 Antithrombotic surface treating agent and medical apparatus
07/08/2003US6589266 Thrombosis filter having a surface treatment
07/08/2003US6589215 Hydrophilic lubricity coating for medical devices comprising a hydrophobic top coat
07/08/2003CA2115651C Medicament coated refractive anterior chamber ocular implant
07/03/2003WO2003053489A2 Surface coating method and coated device
07/03/2003WO2003053218A2 Implant coatings
07/03/2003US20030124705 Thrombolytic agents; mucopolysaccharides; anticoagulants; proteolytic enzymes; blood coagulation factor x
07/02/2003EP1322351A1 Coated medical devices
07/02/2003EP1322235A1 Coated medical devices
06/2003
06/26/2003US20030120198 Spray dry process for applying anticoagulant on a syringe barrel
06/26/2003US20030117579 Medical devices having antimicrobial coatings thereon
06/25/2003EP1112097B1 New process for preparing surface modification substances
06/25/2003EP1098670B1 Crosslinking of bioprosthetic material to mitigate post-implantation calcification
06/24/2003US6583251 Modular cytomimetic biomaterials, transport studies, preparation and utilization thereof
06/19/2003WO2003049795A2 Medical devices comprising nanocomposites
06/19/2003WO2003024499A3 Water-soluble coating for bioactive devices
06/19/2003US20030113478 Plasma treating until a desired surface density of active species is formed; converting to a stable functional group; and optionally covalently attaching the modifying group to said group and reacting with a bioactive material
06/19/2003US20030113477 Non-fouling, wettable coated devices
06/19/2003US20030113314 Heparin directly linked to antithrombin III by a covalent linkage comprises atleast one primary amino group, via a linkage between primary amino group of antithrombin III and terminal residue of heparin; anticoagulant; prosthetics
06/17/2003US6579978 Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
06/12/2003US20030109897 Recoilable thrombosis filtering device and method
06/12/2003US20030108595 Prevent deposits of amyloid; using sulfonate or sulfate compound
06/11/2003EP1317253A2 Biological component comprising artificial membrane
06/10/2003US6576245 Primary package containing aqueous solution for parenteral administration comprising low molecular weight peptide-based thrombin inhibitor or salt,and having specified pH, sealed with rubber stopper or plunger containing bromobutyl rubber
06/10/2003CA2225096C Method of applying drug-release coatings
06/05/2003WO2003045466A2 Catheter composition and uses thereof
06/05/2003CA2467645A1 Composition for removing fibrin-bound blood clots from a catheter
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP0874648B1 Method for making heparinized biomaterials
06/03/2003US6572651 Stents with a diamond like coating
06/03/2003US6572642 Method for treating a prosthesis having an apertured structure and associated devices
05/2003
05/30/2003WO2003043656A1 Drug for preventing vascular restenosis and instrument to be embedded in vessel coated with the drug
05/29/2003US20030100487 Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
05/29/2003US20030099684 Electropolymerizable monomers and polymeric coatings on implantable devices
05/29/2003US20030099683 Having excellent biocompatible properties and imparting bacterial resistance to a coating of an article such as a medical device
05/28/2003EP1225946A4 Coating having biological activity and medical implant having surface carrying the same and method
05/28/2003EP0977604B1 Self-aggregating protein compositions and use as sealants
05/22/2003WO2003041759A1 Spray dry process for applying anticoagulant on a syringe barrel
05/22/2003WO2003041754A1 Medical devices having antimicrobial coatings thereon
05/22/2003US20030097120 Bioactive surface modifiers for polymers and articles made therefrom
05/22/2003US20030096816 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
05/22/2003CA2460027A1 Medical devices having antimicrobial coatings thereon
05/21/2003EP1312635A2 Dental implants having bacterial resistance
05/21/2003EP1311572A2 Biocidal polyurethane compositions and method of use
05/21/2003EP1311551A1 Bioactive coating compositions and methods
05/21/2003EP1311488A1 Substituted imidazoles as tafia inhibitors
05/21/2003CN1418707A Anticoagulant hemodialysis liquid
05/15/2003WO2003039768A1 Method for coating a medical device using uv laserto ablate exce ss coating
05/15/2003WO2002038649A3 Two dimensional polyamides prepared from unsaturated carboxylic acids and amines
05/15/2003US20030093107 Medical devices comprising nanocomposites
05/15/2003US20030091827 Formed from N-trimethylsilyl-allylamine, ethylene, propylene and allyl alcohol; for use on medical equipment, cosmetics
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 58